Literature DB >> 1692550

Markers of fibrogenesis and basement membrane formation in alcoholic liver disease. Relation to severity, presence of hepatitis, and alcohol intake.

O Niemelä1, J Risteli, J E Blake, L Risteli, K V Compton, H Orrego.   

Abstract

This study investigated the relationships of the serum markers of fibrogenesis and basement membrane formation to the clinical and morphological severity of alcoholic liver disease and to the degree of alcohol abuse. The concentrations of the aminoterminal propeptide of type III collagen, type IV collagen, and laminin were measured from 87 samples representing a wide range of clinical and histological severities of the disease, which were assessed with indices that have been shown to correlate well with the risk of dying within 1 yr. Significant correlations (p less than 0.00001) were found between the markers of connective tissue metabolism and the Combined Clinical and Laboratory Index: (aminoterminal propeptide of type III collagen, rs = 0.82; type IV collagen, rs = 0.82; laminin, rs = 0.81), as well as between these markers and the Combined Morphological Index: (aminoterminal propeptide of type III collagen, rs = 0.70; type IV collagen, rs = 0.68; laminin, rs = 0.64). Whereas the patients with less than 8 mM of alcohol in their morning urine (mild or moderate drinkers) showed a significant (p less than 0.00001) decrease in these markers in a period of 27 +/- 1 wk, the patients with more than 8 mM of urinary alcohol (heavy drinkers) had no improvement. It is proposed that both fibrogenesis and basement membrane formation are associated with disease severity, degree of alcoholic hepatitis, and alcohol intake, which are important determinants of prognosis in alcoholic liver disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692550     DOI: 10.1016/0016-5085(90)91098-q

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.

Authors:  C Hirayama; H Suzuki; A Takada; K Fujisawa; K Tanikawa; S Igarashi
Journal:  J Gastroenterol       Date:  1996-04       Impact factor: 7.527

2.  Noninvasive determination of liver collagen content in chronic hepatitis. Multivariate regression modeling with blood chemical parameters as variables.

Authors:  S Takamatsu; H Nakabayashi; Y Okamoto; H Nakano
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

3.  Changes in laminin immunoreactivity as a marker for the state of liver preservation.

Authors:  F Quondamatteo; K Scharif; R Herken
Journal:  Histochem J       Date:  1994-11

4.  Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease.

Authors:  F Stickel; R Urbaschek; D Schuppan; G Poeschl; C Oesterling; C Conradt; R S McCuskey; U A Simanowski; H K Seitz
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

Review 5.  Hepatic fibrosis: are any of the serum markers useful?

Authors:  S Oh; N H Afdhal
Journal:  Curr Gastroenterol Rep       Date:  2001-02

6.  Serum concentrations of laminin in cirrhosis of the liver.

Authors:  J Collazos; F Díaz; J Genollá
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

Review 7.  Is there a place for serum laminin determination in patients with liver disease and cancer?

Authors:  Heitor Rosa; Edison Roberto Parise
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

8.  Serum type IV collagen level is predictive for esophageal varices in patients with severe alcoholic disease.

Authors:  Satoshi Mamori; Yasuyuki Searashi; Masato Matsushima; Kenichi Hashimoto; Shinichiro Uetake; Hiroshi Matsudaira; Shuji Ito; Hisato Nakajima; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

9.  Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis.

Authors:  Zarko Babić; Ante Bilić; Dobroslav Babić; Vjekoslav Jagić; Branko Nikolić; Martina Sunić
Journal:  Wien Klin Wochenschr       Date:  2003-05-15       Impact factor: 1.704

10.  Study of serum procollagen type III peptide in patients with hepatic cirrhosis from a clinical point of view.

Authors:  F Díaz; J Collazos; J Genollá
Journal:  Clin Investig       Date:  1993-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.